Article

ACC 2011 Interview on Cost Analysis Substituting Dabigatran for Warfarin

Dr. Julie Atay discusses her poster at ACC 2011 on "Cost Analysis of Substituting Dabigatran for Warfarin in an Anticoagulant Management Program."

Related Videos
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Erin Weber, MS
Lynae Darbes, PhD
Kenny Cole, MD
Richard Lafayette, MD, FACP, Stanford University Medical Center
Craig A. Portell, MD, UVA Health
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Dr Johnie Rose
Andrew Kuykendall, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo